These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Steg PG; Bonnefoy E; Chabaud S; Lapostolle F; Dubien PY; Cristofini P; Leizorovicz A; Touboul P; Circulation; 2003 Dec; 108(23):2851-6. PubMed ID: 14623806 [TBL] [Abstract][Full Text] [Related]
25. Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction. Barbash GI; Roth A; Hod H; Miller HI; Rath S; Har-Zahav Y; Modan M; Seligsohn U; Battler A; Kaplinsky E Br Heart J; 1990 Oct; 64(4):241-7. PubMed ID: 2121199 [TBL] [Abstract][Full Text] [Related]
26. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. Schömig A; Kastrati A; Dirschinger J; Mehilli J; Schricke U; Pache J; Martinoff S; Neumann FJ; Schwaiger M N Engl J Med; 2000 Aug; 343(6):385-91. PubMed ID: 10933737 [TBL] [Abstract][Full Text] [Related]
27. Tenecteplase: new preparation. Another thrombolytic agent for myocardial infarction: a slightly simpler treatment. Prescrire Int; 2002 Jun; 11(59):83-4. PubMed ID: 12068843 [TBL] [Abstract][Full Text] [Related]
28. Ridogrel does not increase the speed and rate of coronary recanalization in patients with myocardial infarction treated with alteplase and heparin. Tranchesi B; Pileggi F; Vercammen E; Van de Werf F; Verstraete M Eur Heart J; 1994 May; 15(5):660-4. PubMed ID: 8056007 [TBL] [Abstract][Full Text] [Related]
29. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy]. Kobusiak-Prokopowicz M; Mysiak A Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704 [TBL] [Abstract][Full Text] [Related]
30. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct]. Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123 [TBL] [Abstract][Full Text] [Related]
31. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. Andreotti F; Pasceri V; Hackett DR; Davies GJ; Haider AW; Maseri A N Engl J Med; 1996 Jan; 334(1):7-12. PubMed ID: 7494588 [TBL] [Abstract][Full Text] [Related]
32. Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI. Möckel M; Bocksch W; Strohm S; Kühnle Y; Vollert J; Nibbe L; Dietz R Int J Cardiol; 2005 Aug; 103(2):193-200. PubMed ID: 16080980 [TBL] [Abstract][Full Text] [Related]
33. Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA). Gibson CM; Marble SJ Clin Cardiol; 2001 Sep; 24(9):577-84. PubMed ID: 11558838 [TBL] [Abstract][Full Text] [Related]
34. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). Le May MR; Wells GA; Labinaz M; Davies RF; Turek M; Leddy D; Maloney J; McKibbin T; Quinn B; Beanlands RS; Glover C; Marquis JF; O'Brien ER; Williams WL; Higginson LA J Am Coll Cardiol; 2005 Aug; 46(3):417-24. PubMed ID: 16053952 [TBL] [Abstract][Full Text] [Related]
35. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
36. Use of alteplase for myocardial infarction in two community hospitals. Krichbaum DW; Grabavoy G; Finley RC; Hamid I Am J Hosp Pharm; 1990 Jul; 47(7):1535-40. PubMed ID: 2114788 [TBL] [Abstract][Full Text] [Related]
37. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Armstrong PW; Eur Heart J; 2006 Jul; 27(13):1530-8. PubMed ID: 16757491 [TBL] [Abstract][Full Text] [Related]
38. Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis. Wilcox RG; von der Lippe G; Olsson CG; Jensen G; Skene AM; Hampton JR Lancet; 1990 May; 335(8699):1175-8. PubMed ID: 1971034 [TBL] [Abstract][Full Text] [Related]
39. Tenecteplase in the treatment of acute myocardial infarction. Chandra KS; Jariwala P; Lathi P Indian Heart J; 2009; 61(5):437-42. PubMed ID: 20635758 [No Abstract] [Full Text] [Related]
40. Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction. Melandri G; Vagnarelli F; Calabrese D; Semprini F; Nanni S; Branzi A Vasc Health Risk Manag; 2009; 5(1):249-56. PubMed ID: 19436656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]